BIPH jumping today on yesterdays PR:
Biophan Technologies (OTCBB BIPH) Wednesday's market went up 10.29% to $0.750 per share, with a total of 498,051 shares traded. Biophan Technologies, Inc., a developer of next-generation medical technology, announced full congressional approval of an allocation of $1 million in U.S. government funding to help accelerate the commercialization of the MYO-VAD(TM) cardiac recovery system. A previously announced additional allocation of $400,000 is still pending. The U.S. Congress approved the expenditure on September 26, with the passage of the Department of Defense Appropriations Bill for Fiscal Year 2007. The MYO-VAD cardiac recovery system is being developed to provide short-term support and recovery capability to damaged or diseased hearts. "This appropriation will help extend the availability of our technology to heart failure patients at locations outside of the very limited number of specialized hospitals, including suburban or rural areas and advanced military units," said Jeffrey L. Helfer, President of Biophan's Cardiovascular Division.
Biophan Technologies is engaged in designing, developing, and marketing new technology and related products to enable cardiac pacemakers and other life sustaining medical devices to be safe and compatible with magnetic resonance imaging (MRI) and other equipment using magnetic fields and radio waves. This MRI-compatible technology will be utilized in implantable pacemakers, implantable cardioverter defibrillators, and other medical equipment.
Send stock manipulators to: enforcement@sec.gov-and to jail.
AI
